Ken Griffin’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$104M Buy
2,570,840
+2,101,133
+447% +$89.3M 0.01% 970
2026
Q2
$19.1M Buy
469,707
+40,675
+9% +$1.4M ﹤0.01% 2652
2026
Q1
$13.5M Buy
429,032
+305,935
+249% +$8.82M ﹤0.01% 2823
2025
Q4
$3.05M Buy
123,097
+100,780
+452% +$2.02M ﹤0.01% 5117
2025
Q3
$362K Sell
22,317
-302,932
-93% -$4.3M ﹤0.01% 9914
2025
Q2
$4.26M Buy
325,249
+227,971
+234% +$3.29M ﹤0.01% 4395
2025
Q1
$2.14M Sell
97,278
-372,173
-79% -$9.8M ﹤0.01% 5404
2024
Q4
$12.5M Sell
469,451
-68,798
-13% -$2.19M ﹤0.01% 2691
2024
Q3
$14.4M Sell
538,249
-1,810,925
-77% -$36M ﹤0.01% 2428
2024
Q2
$42.3M Sell
2,349,174
-370,117
-14% -$6.46M 0.01% 1285
2024
Q1
$49.6M Buy
2,719,291
+133,361
+5% +$2.12M 0.01% 1218
2023
Q4
$28.3M Sell
2,585,930
-181,506
-7% -$1.27M 0.01% 1680
2023
Q3
$15.9M Buy
2,767,436
+92,446
+3% +$628K ﹤0.01% 2128
2023
Q2
$20.7M Sell
2,674,990
-93,448
-3% -$788K ﹤0.01% 1844
2023
Q1
$18.5M Sell
2,768,438
-78,081
-3% -$724K ﹤0.01% 2003
2022
Q4
$25.4M Buy
2,846,519
+84,795
+3% +$795K 0.01% 1715
2022
Q3
$27.2M Buy
2,761,724
+223,706
+9% +$2.26M 0.01% 1579
2022
Q2
$20.2M Sell
2,538,018
-101,782
-4% -$769K 0.01% 1845
2022
Q1
$25.6M Buy
2,639,800
+181,359
+7% +$2.33M 0.01% 1714
2021
Q4
$37.6M Buy
2,458,441
+33,257
+1% +$598K 0.01% 1411
2021
Q3
$40.3M Sell
2,425,184
-34,967
-1% -$632K 0.01% 1296
2021
Q2
$51.2M Buy
2,460,151
+78,003
+3% +$2.13M 0.01% 1105
2021
Q1
$77.4M Buy
+2,382,148
New +$77.2M 0.02% 733

Other funds holding EWTX

Ken Griffin's EWTX Position: Q3 2026 in Review

Ken Griffin increased its Edgewise Therapeutics (EWTX) stake by 447% in Q3 2026, buying an estimated $89.3M and bringing the position to 2,570,840 shares worth $104M. The position accounts for 0.01% of the portfolio, ranked #970.

Ken Griffin first reported a position in EWTX in Q1 2021 and has held it in 23 quarters since. 253 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • Ken Griffin held 2,570,840 shares of Edgewise Therapeutics worth $104M as of Q3 2026.
  • Ken Griffin bought 2,101,133 Edgewise Therapeutics shares in Q3 2026, an estimated $89.3M.
  • Edgewise Therapeutics made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #970 holding.
  • Ken Griffin first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 23 quarters since.
  • 253 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.